1887

Chapter 19 : , , and Other Catalase-Positive Cocci

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

, , and Other Catalase-Positive Cocci , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap19-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap19-2.gif

Abstract:

Historically, the genera and were placed together with the genera and in the family containing grampositive, catalase-positive cocci. An unrelated species of gram-positive cocci exhibiting positive catalase reaction and occurring in human specimens is , the only species of this genus, which is a member of the family belonging to the order . In this chapter, the term "micrococci" is used to indicate the members of the genus as understood before the emendation, reflecting most of the clinically relevant species. The genus comprises four hoofed-animal-adapted species including , first described as . species can be identified phenotypically on the basis of a variety of conventional characteristics. The diagnosis of staphylococcal toxic shock syndrome (TSS) and staphylococcal scalded skin syndrome (SSSS) is based on clinical signs supplemented by serologic tests and the detection of the toxin production by staphylococcal isolates (, rarely other species). Detection of methicillin-resistant (MRSA) represents the most important task in determining the antimicrobial susceptibilities of staphylococci. Coagulase-negative staphylococci (CoNS) are an important cause of nosocomial bloodstream infections, but they are also the most common contaminants of blood cultures. The considerations of clinical significance discussed for CoNS are also appropriate for members of the and families; however, the criteria used for distinguishing etiologically relevant isolates from contaminants and colonizers, respectively, should be applied much more strictly.

Citation: Becker K, von Eiff C. 2011. , , and Other Catalase-Positive Cocci , p 308-330. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch19

Key Concept Ranking

Multiple-Locus Variable-Number Tandem-Repeat Analysis
0.43461612
Restriction Fragment Length Polymorphism
0.42622125
Antimicrobial Susceptibility Testing
0.41990376
0.43461612
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Columbia blood agar plate with 5% sheep blood showing subsp. after 24 h of incubation displaying the typical shapes of the normal phenotype with golden yellow-pigmented colonies surrounded by a hemolysis zone (left) and of the small-colony phenotype characterized by tiny, nonhemolytic, and nonpigmented colonies (right).

Citation: Becker K, von Eiff C. 2011. , , and Other Catalase-Positive Cocci , p 308-330. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch19
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap19
1. Aguirre, M.,, and M. D. Collins. 1992. Development of a polymerase chain reaction-probe test for identification of Alloiococcus otitis. J. Clin. Microbiol. 30:21772180.
2. Albrich, W. C.,, and S. Harbarth. 2008. Health-care workers: source, vector, or victim of MRSA? Lancet Infect. Dis. 8:289301.
3. Altuntas, F.,, O. Yildiz,, B. Eser,, K. Gundogan,, B. Sumerkan,, and M. Cetin. 2004. Catheter-related bacteremia due to Kocuria rosea in a patient undergoing peripheral blood stem cell transplantation. BMC Infect. Dis. 4:62.
4. Alves, M.,, C. Nogueira,, A. de Magalhães-Sant’Ana,, A. P. Chung,, P. V. Morais,, and M. S. da Costa. 2008. Nosocomiicoccus ampullae gen. nov., sp. nov., isolated from the surface of bottles of saline solution used in wound cleansing. Int. J. Syst. Evol. Microbiol. 58:29392944.
5. Amiali, N. M.,, M. R. Mulvey,, B. Berger-Bächi,, J. Sedman,, A. E. Simor,, and A. A. Ismail. 2008. Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus. J. Antimicrob. Chemother. 61:95102.
6. Amiali, N. M.,, M. R. Mulvey,, J. Sedman,, M. Louie,, A. E. Simor,, and A. A. Ismail. 2007. Rapid identification of coagulase-negative staphylococci by Fourier transform infrared spectroscopy. J. Microbiol. Methods 68:236242.
7. Amiali, N. M.,, M. R. Mulvey,, J. Sedman,, A. E. Simor,, and A. A. Ismail. 2007. Epidemiological typing of methicillinresistant Staphylococcus aureus strains by Fourier transform infrared spectroscopy. J. Microbiol. Methods 69:146153.
8. Anguera, I.,, A. DelRío,, J. M. Miró,, X. Matínez-Lacasa,, F. Marco,, J. R. Gumá,, G. Quaglio,, X. Claramonte,, A. Moreno,, C. A. Mestres,, E. Mauri,, M. Azqueta,, N. Benito,, C. García-de la Maria,, M. Almela,, M. J. Jiménez-Expósito,, O. Sued,, E. De Lazzari,, and J. M. Gatell. 2005. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91:e10.
9. Appelbaum, P. C. 2007. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents 30:398408.
10. Ashhurst-Smith, C.,, S. T. Hall,, P. Walker,, J. Stuart,, P. M. Hansbro,, and C. C. Blackwell. 2007. Isolation of Alloiococcus otitidis from Indigenous and non-Indigenous Australian children with chronic otitis media with effusion. FEMS Immunol. Med. Microbiol. 51:163170.
11. Atkins, B. L.,, N. Athanasou,, J. J. Deeks,, D. W. Crook,, H. Simpson,, T. E. Peto,, P. McLardy-Smith,, A. R. Berendt, et al. 1998. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J. Clin. Microbiol. 36:29322939.
12. Baba, T.,, K. Kuwahara-Arai,, I. Uchiyama,, F. Takeuchi,, T. Ito,, and K. Hiramatsu. 2009. Complete genome sequence of Macrococcus caseolyticus strain JCSCS5402, reflecting the ancestral genome of the human-pathogenic staphylococci. J. Bacteriol. 191:11801190.
13. Baba, T.,, F. Takeuchi,, M. Kuroda,, H. Yuzawa,, K. Aoki,, A. Oguchi,, Y. Nagai,, N. Iwama,, K. Asano,, T. Naimi,, H. Kuroda,, L. Cui,, K. Yamamoto,, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:18191827.
14. Baird-Parker, A. C. 1963. A classification of micrococci and staphylococci based on physiological and chemical tests. J. Gen. Microbiol. 30:409427.
15. Bannoehr, J.,, N. L. Ben Zakour,, A. S. Waller,, L. Guardabassi,, K. L. Thoday,, A. H. van den Broek,, and J. R. Fitzgerald. 2007. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J. Bacteriol. 189:86858692.
16. Baumert, N.,, C. von Eiff,, F. Schaaff,, G. Peters,, R. A. Proctor,, and H. G. Sahl. 2002. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 8:253260.
17. Becker, K.,, A. W. Friedrich,, G. Lubritz,, M. Weilert,, G. Peters,, and C. von Eiff. 2003. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J. Clin. Microbiol. 41:14341439.
18. Becker, K.,, D. Harmsen,, A. Mellmann,, C. Meier,, P. Schumann,, G. Peters,, and C. von Eiff. 2004. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42:49884995.
19. Becker, K.,, B. Keller,, C. von Eiff,, M. Brück,, G. Lubritz,, J. Etienne,, and G. Peters. 2001. Enterotoxigenic potential of Staphylococcus intermedius. Appl. Environ. Microbiol. 67:55515557.
20. Becker, K.,, N. A. Laham,, W. Fegeler,, R. A. Proctor,, G. Peters,, and C. von Eiff. 2006. Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small-colony variants. J. Clin. Microbiol. 44:32743278.
21. Becker, K.,, I. Pagnier,, B. Schuhen,, F. Wenzelburger,, A. W. Friedrich,, F. Kipp,, G. Peters,, and C. von Eiff. 2006. Does nasal cocolonization by methicillin-resistant coagulase- negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods? J. Clin. Microbiol. 44:229231.
22. Becker, K.,, R. Roth,, and G. Peters. 1998. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36:25482553.
23. Becker, K.,, F. Rutsch,, A. Uekötter,, F. Kipp,, J. König,, T. Marquardt,, G. Peters,, and C. von Eiff. 2008. Kocuria rhizophila adds to the emerging spectrum of micrococcal species involved in human infections. J. Clin. Microbiol. 46:35373539.
24. Becker, K.,, C. von Eiff,, B. Keller,, M. Brück,, J. Etienne,, and G. Peters. 2005. Thermonuclease gene as a target for specific identification of Staphylococcus intermedius isolates: use of a PCR-DNA enzyme immunoassay. Diagn. Microbiol. Infect. Dis. 51:237244.
25. Becker, K.,, J. Wüllenweber,, H. J. Odenthal,, M. Moeller,, P. Schumann,, G. Peters,, and C. von Eiff. 2003. Prosthetic valve endocarditis due to Kytococcus schroeteri. Emerg. Infect. Dis. 9:14931495.
26. Beekmann, S. E.,, D. J. Diekema,, and G. V. Doern. 2005. Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect. Control Hosp. Epidemiol. 26:559566.
27. Berglund, C.,, T. Ito,, M. Ikeda,, X. X. Ma,, B. Söderquist,, and K. Hiramatsu. 2008. Novel type of staphylococcal cassette chromosome mec in a methicillin-resistant Staphylococcus aureus strain isolated in Sweden. Antimicrob. Agents Chemother. 52:35123516.
28. Bieber, L.,, and G. Kahlmeter. 2009. Staphylococcus lugdunensis in several niches of the normal skin flora. Clin. Microbiol. Infect. 16:385388.
29. Bosley, G. S.,, A. M. Whitney,, J. M. Pruckler,, C. W. Moss,, M. Daneshvar,, T. Sih,, and D. F. Talkington. 1995. Characterization of ear fluid isolates of Alloiococcus otitidis from patients with recurrent otitis media. J. Clin. Microbiol. 33:28762880.
30. Boyle-Vavra, S.,, H. Labischinski,, C. C. Ebert,, K. Ehlert,, and R. S. Daum. 2001. A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 45:280287.
31. Brakstad, O. G.,, K. Aasbakk,, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30:16541660.
32. Carbonnelle, E.,, J. L. Beretti,, S. Cottyn,, G. Quesne,, P. Berche,, X. Nassif,, and A. Ferroni. 2007. Rapid identification of staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 45:21562161.
33.Centers for Disease Controland Prevention. 1997. Staphylococcus aureus with reducedsusceptibility to vancomycin—United States, 1997. MMWR Morb. Mortal.Wkly. Rep. 46:765766.
34.Centers for Disease Controland Prevention. 2002. Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR Morb. Mortal. Wkly.Rep. 51:565567.
35. Charles, P. G.,, P. B. Ward,, P. D. Johnson,, B. P. Howden,, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448451.
36. Cherkaoui, A.,, G. Renzi,, P. Francois,, and J. Schrenzel. 2007. Comparison of four chromogenic media for culturebased screening of meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 56:500503.
37. Chow, J. W.,, and V. L. Yu. 1989. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch. Intern. Med. 149:12581262.
38.Clinical and Laboratory Standards Institute. 2009. Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria That Grow Aerobically; Approved Standard—Eighth ed. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
39.Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
40. Collins, M. D.,, R. A. Hutson,, V. Baverud,, and E. Falsen. 2000. Characterization of a Rothia-like organism from a mouse: description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. Int. J. Syst. Evol. Microbiol. 50:12471251.
41. Couto, I.,, S. Pereira,, M. Miragaia,, I. S. Sanches,, and H. de Lencastre. 2001. Identification of clinical staphylococcal isolates from humans by internal transcribed spacer PCR. J. Clin. Microbiol. 39:30993103.
42. Cui, L.,, X. Ma,, K. Sato,, K. Okuma,, F. C. Tenover,, E. M. Mamizuka,, C. G. Gemmell,, M. N. Kim,, M. C. Ploy,, N. El-Solh,, V. Ferraz,, and K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:514.
43. Curtis, C.,, and N. Shetty. 2008. Recent trends and prevention of infection in the neonatal intensive care unit. Curr. Opin. Infect. Dis. 21:350356.
44. Daum, R. S.,, T. Ito,, K. Hiramatsu,, F. Hussain,, K. Mongkolrattanothai,, M. Jamklang,, and S. Boyle-Vavra. 2002. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J. Infect. Dis. 186:13441347.
45. de la Fuente, R.,, G. Suarez,, and K. H. Schleifer. 1985. Staphylococcus aureus subsp. anaerobius subsp. nov., the causal agent of abscess disease of sheep. Int. J. Syst. Bacteriol. 35:99102.
46. de Miguel Martínez, I.,, and A. R. Macías. 2008. Serous otitis media in children: implication of Alloiococcus otitidis. Otol. Neurotol. 29:526530.
47. Deurenberg, R. H.,, and E. E. Stobberingh. 2009. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr. Mol. Med. 9:100115.
48. Devriese, L. A.,, M. Vancanneyt,, M. Baele,, M. Vaneechoutte,, E. De Graef,, C. Snauwaert,, I. Cleenwerck,, P. Dawyndt,, J. Swings,, A. Decostere,, and F. Haesebrouck. 2005. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int. J. Syst. Evol. Microbiol. 55:15691573.
49. Diederen, B.,, I. van Duijn,, A. van Belkum,, P. Willemse,, P. Van Keulen,, and J. Kluytmans. 2005. Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:19251927.
50. Diekema, D. J.,, B. J. BootsMiller,, T. E. Vaughn,, R. F. Woolson,, J. W. Yankey,, E. J. Ernst,, S. D. Flach,, M. M. Ward,, C. L. Franciscus,, M. A. Pfaller,, and B. N. Doebbeling. 2004. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin. Infect. Dis. 38:7885.
51. Diekema, D.J.,, M. A. Pfaller,, F. J. Schmitz,, J. Smayevsky,, J. Bell,, R. N. Jones,, and M. Beach. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2): S114S132.
52. Diep, B. A.,, H. F. Chambers,, C. J. Graber,, J. D. Szumowski,, L. G. Miller,, L. L. Han,, J. H. Chen,, F. Lin,, J. Lin,, T. H. Phan,, H. A. Carleton,, L. K. McDougal,, F. C. Tenover,, D. E. Cohen,, K. H. Mayer,, G. F. Sensabaugh,, and F. Perdreau- Remington. 2008. Emergence of multidrug- resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148:249257.
53. Donnio, P. Y.,, D. C. Oliveira,, N. A. Faria,, N. Wilhelm,, A. Le Coustumier,, and H. de Lencastre. 2005. Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus. J. Clin. Microbiol. 43:41914193.
54. Draghi, D. C.,, S. Tench,, M. J. Dowzicky,, and D. F. Sahm. 2008. Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance. Chemotherapy 54:91100.
55. Edwards, K. J.,, M. E. Kaufmann,, and N. A. Saunders. 2001. Rapid and accurate identification of coagulase- negative staphylococci by real-time PCR. J. Clin. Microbiol. 39:30473051.
56. Eigner, U.,, A. Schmid,, U. Wild,, D. Bertsch,, and A. M. Fahr. 2005. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J. Clin. Microbiol. 43:38293834.
57. el Solh, N.,, M. Davi,, A. Morvan,, H. A. Damon,, and N. Marty. 2003. Characteristics of French methicillin- resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides. J. Antimicrob. Chemother. 52:691694.
58. Enright, M. C.,, N. P. Day,, C. E. Davies,, S. J. Peacock,, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:10081015.
59. Faller, A.,, and K. H. Schleifer. 1981. Modified oxidase and benzidine tests for separation of staphylococci from micrococci. J. Clin. Microbiol. 13:10311035.
60. Felten, A.,, B. Grandry,, P. H. Lagrange,, and I. Casin. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J. Clin. Microbiol. 40:27662771.
61. Fischer, A.,, C. von Eiff,, T. Kuczius,, K. Omoe,, G. Peters,, and K. Becker. 2007. A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins. J. Mol. Med. 85:461469.
62. Fluit, A. C.,, C. L. Wielders,, J. Verhoef,, and F. J. Schmitz. 2001. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J. Clin. Microbiol. 39:37273732.
63. Fowler, V. G., Jr.,, H. W. Boucher,, G. R. Corey,, E. Abrutyn,, A. W. Karchmer,, M. E. Rupp,, D. P. Levine,, H. F. Chambers,, F. P. Tally,, G. A. Vigliani,, C. H. Cabell,, A. S. Link,, I. DeMeyer,, S. G. Filler,, M. Zervos,, P. Cook,, J. Parsonnet,, J. M. Bernstein,, C. S. Price,, G. N. Forrest,, G. Fätkenheuer,, M. Gareca,, S. J. Rehm,, H. R. Brodt,, A. Tice,, and S. E. Cosgrove. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653665.
64. Fraise, A.P. 2002. Susceptibility ofantibiotic-resistant cocci to biocides. J. Appl. Microbiol. 92(Suppl.):158S162S.
65. Frénay, H. M.,, A. E. Bunschoten,, L. M. Schouls,, W. J. van Leeuwen,, G. C. Vandenbroucke,, J. Verhoef,, and F. R. Mooi. 1996. Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur. J. Clin. Microbiol. Infect. Dis. 15:6064.
66. Frye, J. G.,, T. Jesse,, F. Long,, G. Rondeau,, S. Porwollik,, M. McClelland,, C. R. Jackson,, M. Englen,, and P. J. Fedorka- Cray. 2006. DNA microarray detection of antimicrobial resistance genes in diverse bacteria. Int. J. Antimicrob. Agents 27:138151.
67. García de Viedma, D.,, P. Martín Rabadán,, M. Díaz,, E. Cercenado,, and E. Bouza. 2000. Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase- negative staphylococci isolated from catheters. J. Clin. Microbiol. 38:13591363.
68. Garrity, G. M.,, K. L. Johnson,, J. Bell,, and D. B. Searles. 2004. Taxonomic Outline of the Procaryotes. Bergey’s Manual of Systematic Bacteriology, 2nd ed., release 5.0. Springer-Verlag, New York, NY.
69. Geary, C.,, J. Z. Jordens,, J. F. Richardson,, D. M. Hawcroft,, and C. J. Mitchell. 1997. Epidemiological typing of coagulase- negative staphylococci from nosocomial infections. J. Med. Microbiol. 46:195203.
70. Gemmell, C. G.,, D. I. Edwards,, A. P. Fraise,, F. K. Gould,, G. L. Ridgway,, and R. E. Warren. 2006. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 57:589608.
71. Gilbert, D. N.,, R. C. Moellering,Jr.,, G. M. Eliopoulos,, H. F. Chambers,, and M. S. Saag. 2009. The Sanford Guide to Antimicrobial Therapy. Antimicrobial Therapy, Sperryville, VA.
72. Gillet, Y.,, B. Issartel,, P. Vanhems,, J. C. Fournet,, G. Lina,, M. Bes,, F. Vandenesch,, Y. Piemont,, N. Brousse,, D. Floret,, and J. Etienne. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753759.
73. Goh, S. H.,, S. Potter,, J. O. Wood,, S. M. Hemmingsen,, R. P. Reynolds,, and A. W. Chow. 1996. HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci. J. Clin. Microbiol. 34:818823.
74. Goh, S. H.,, Z. Santucci,, W. E. Kloos,, M. Faltyn,, C. G. George,, D. Driedger,, and S. M. Hemmingsen. 1997. Identification of Staphylococcus species and subspecies by the chaperonin 60 gene identification method and reverse checkerboard hybridization. J. Clin. Microbiol. 35:31163121.
75. Goldman, M.,, U. B. Chaudhary,, A. Greist,, and C. A. Fausel. 1998. Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts. Clin. Infect. Dis. 27:12411246.
76. Granlund, M.,, M. Linderholm,, M. Norgren,, C. Olofsson,, A. Wahlin,, and S. E. Holm. 1996. Stomatococcus mucilaginosus septicemia in leukemic patients. Clin. Microbiol. Infect. 2:179185.
77. Guignard, B.,, J. M. Entenza,, and P. Moreillon. 2005. Betalactams against methicillin-resistant Staphylococcus aureus. Curr. Opin. Pharmacol. 5:479489.
78. Hajjeh, R. A.,, A. Reingold,, A. Weil,, K. Shutt,, A. Schuchat,, and B. A. Perkins. 1999. Toxic shock syndrome inthe United States: surveillance update, 1979–1996. Emerg. Infect. Dis. 5:807810.
79. Hall, K. K.,, and J. A. Lyman. 2006. Updated review of blood culture contamination. Clin. Microbiol. Rev. 19:788802.
80. Harimaya, A.,, N. Fujii,, and T. Himi. 2009. Preliminary study of proinflammatory cytokines and chemokines in the middle ear of acute otitis media due to Alloiococcus otitidis. Int. J. Pediatr. Otorhinolaryngol. 73:677680.
81. Harmsen, D.,, H. Claus,, W. Witte,, J. Rothgänger,, H. Claus,, D. Turnwald,, and U. Vogel. 2003. Typing of methicillinresistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:54425448.
82. Hendolin, P. H.,, A. Markkanen,, J. Ylikoski,, and J. J. Wahlfors. 1997. Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions. J. Clin. Microbiol. 35:28542858.
83. Hensley, D. M.,, R. Tapia,, and Y. Encina. 2009. An evaluation of the advandx Staphylococcus aureus/CNS PNA FISH assay. Clin. Lab. Sci. 22:3033.
84. Hidron, A. I.,, J. R. Edwards,, J. Patel,, T. C. Horan,, D. M. Sievert,, D. A. Pollock,, and S. K. Fridkin. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:9961011.
85. Hidron, A. I.,, C. E. Low,, E. G. Honig,, and H. M. Blumberg. 2009. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect. Dis. 9:384392.
86. Hiramatsu, K.,, N. Aritaka,, H. Hanaki,, S. Kawasaki,, Y. Hosoda,, S. Hori,, Y. Fukuchi,, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:16701673.
87. Hope, R.,, D. M. Livermore,, G. Brick,, M. Lillie,, and R. Reynolds. 2008. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J. Antimicrob. Chemother. 62(Suppl. 2):ii65ii74.
88. Huijsdens, X. W.,, B. J. van Dijke,, E. Spalburg,, M. G. van Santen-Verheuvel,, M. E. Heck,, G. N. Pluister,, A. Voss,, W. J. Wannet,, and A. J. de Neeling. 2006. Community-acquired MRSA and pig-farming. Ann. Clin. Microbiol. Antimicrob. 5:26.
89. Huletsky, A.,, R. Giroux,, V. Rossbach,, M. Gagnon,, M. Vaillancourt,, M. Bernier,, F. Gagnon,, K. Truchon,, M. Bastien,, F. J. Picard,, A. van Belkum,, M. Ouellette,, P. H. Roy,, and M. G. Bergeron. 2004. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J. Clin. Microbiol. 42:18751884.
90. Ito, T.,, Y. Katayama,, K. Asada,, N. Mori,, K. Tsutsumimoto,, C. Tiensasitorn,, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin- resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:13231336.
91. Ito, T.,, X. X. Ma,, F. Takeuchi,, K. Okuma,, H. Yuzawa,, and K. Hiramatsu. 2004. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother. 48:26372651.
92. Jensen, M. A.,, J. A. Webster,, and N. Straus. 1993. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol. 59:945952.
93. John, J. F.,, and A. M. Harvin. 2007. History and evolution of antibiotic resistance in coagulase-negative staphylococci: susceptibility profiles of new anti-staphylococcal agents. Ther. Clin. Risk Manag. 3:11431152.
94. Joubert, O.,, D. Keller,, A. Pinck,, H. Monteil,, and G. Prevost. 2005. Sensitive and specific detection of staphylococcal epidermolysins A and B in broth cultures by flow cytometry-assisted multiplex immunoassay. J. Clin. Microbiol. 43:10761080.
95. Jourdain, S.,, D. Miendje,, V. K. Musampa,, G. Wauters,, O. Denis,, P. Lepage,, and A. Vergison. 2009. Kytococcus schroeteri infection of a ventriculoperitoneal shunt in a child. Int. J. Infect. Dis. 13:e153e155.
96. Kahl, B.,, M. Herrmann,, A. S. Everding,, H. G. Koch,, K. Becker,, E. Harms,, R. A. Proctor,, and G. Peters. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:10231029.
97. Kazakova, S. V.,, J. C. Hageman,, M. Matava,, A. Srinivasan,, L. Phelan,, B. Garfinkel,, T. Boo,, S. McAllister,, J. Anderson,, B. Jensen,, D. Dodson,, D. Lonsway,, L. K. McDougal,, M. Arduino,, V. J. Fraser,, G. Killgore,, F. C. Tenover,, S. Cody,, and D. B. Jernigan. 2005. A clone of methicillinresistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468475.
98. Khatib, R.,, K. Riederer,, S. Saeed,, L. B. Johnson,, M. G. Fakih,, M. Sharma,, M. S. Tabriz,, and A. Khosrovaneh. 2005. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin. Infect. Dis. 41:594598.
99. King, M. D.,, B. J. Humphrey,, Y. F. Wang,, E. V. Kourbatova,, S. M. Ray,, and H. M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309317.
100. Kipp, F.,, K. Becker,, G. Peters,, and C. von Eiff. 2004. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J. Clin. Microbiol. 42:12771279.
101. Klevens, R. M.,, M. A. Morrison,, J. Nadle,, S. Petit,, K. Gershman,, S. Ray,, L. H. Harrison,, R. Lynfield,, G. Dumyati,, J. M. Townes,, A. S. Craig,, E. R. Zell,, G. E. Fosheim,, L. K. McDougal,, R. B. Carey,, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:17631771.
102. Kloos, W. E.,, D. N. Ballard,, C. G. George,, J. A. Webster,, R. J. Hubner,, W. Ludwig,, K. H. Schleifer,, F. Fiedler,, and K. Schubert. 1998. Delimiting the genus Staphylococcus through description of Macrococcus caseolyticus gen. nov., comb. nov. and Macrococcus equipercicus sp. nov., and Macrococcus bovicus sp. no. and Macrococcus carouselicus sp. nov. Int. J. Syst. Bacteriol. 48:859877.
103. Kloos, W. E.,, and T. L. Bannerman. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117140.
104. Kloos, W. E.,, and M. S. Musselwhite. 1975. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl. Microbiol. 30:381385.
105. Kloos, W. E.,, and K. H. Schleifer. 1975. Simplified scheme for routine identification of human Staphylococcus species. J. Clin. Microbiol. 1:8288.
106. Kloos, W. E.,, and K. H. Schleifer. 1983. Staphylococcus auricularis sp. nov.: an inhabitant of the human external ear. Int. J. Syst. Bacteriol. 33:914.
107. Kluytmans, J. A.,, J. W. Mouton,, E. P. Ijzerman,, C. M. Vandenbroucke-Grauls,, A. W. Maat,, J. H. Wagenvoort,, and H. A. Verbrugh. 1995. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171:216219.
108. Kobayashi, N.,, M. Alam,, and S. Urasawa. 2001. Analysis on distribution of insertion sequence IS431 in clinical isolates of staphylococci. Diagn. Microbiol. Infect. Dis. 39:6164.
109. Köck, R.,, J. Harlizius,, N. Bressan,, R. Laerberg,, L. H. Wieler,, W. Witte,, R. H. Deurenberg,, A. Voss,, K. Becker,, and A. W. Friedrich. 2009. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 28: 13751382.
110. Koessler, T.,, P. Francois,, Y. Charbonnier,, A. Huyghe,, M. Bento,, S. Dharan,, G. Renzi,, D. Lew,, S. Harbarth,, D. Pittet,, and J. Schrenzel. 2006. Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:10401048.
111. Krimmer, V.,, H. Merkert,, C. von Eiff,, M. Frosch,, J. Eulert,, J. F. Löhr,, J. Hacker,, and W. Ziebuhr. 1999. Detection of Staphylococcus aureus and Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in situ hybridization. J. Clin. Microbiol. 37:26672673.
112. Ladhani, S.,, C. L. Joannou,, D. P. Lochrie,, R. W. Evans,, and S. M. Poston. 1999. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scaldedskin syndrome. Clin. Microbiol. Rev. 12:224242.
113. Lalani, T.,, Z. A. Kanafani,, V. H. Chu,, L. Moore,, G. R. Corey,, P. Pappas,, C. W. Woods,, C. H. Cabell,, B. Hoen,, C. Selton-Suty,, T. Doco-Lecompte,, C. Chirouze,, D. Raoult,, J. M. Miro,, C. A. Mestres,, L. Olaison,, S. Eykyn,, E. Abrutyn,, and V. G. FowlerJr., 2006. Prosthetic valve endocarditis due to coagulasenegative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur. J. Clin. Microbiol. Infect. Dis. 25:365368.
114. Leskinen, K.,, P. Hendolin,, A. Virolainen-Julkunen,, J. Ylikoski,, and J. Jero. 2002. The clinical role of Alloiococcus otitidis in otitis media with effusion. Int. J. Pediatr. Otorhinolaryngol. 66:4148.
115. Lina, G.,, Y. Piémont,, F. Godail-Gamot,, M. Bes,, M.-O. Peter,, V. Gauduchon,, F. Vandenesch,, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:11281132.
116. Lowry, T. R.,, and J. A. Brennan. 2005. Stomatococcus mucilaginosis infection leading to early cervical necrotizing fasciitis. Otolaryngol. Head Neck Surg. 132:658660.
117. Ludwig, W.,, K. H. Schleifer,, and W. B. Whitman,. 2009. Class I. Bacilli classnov., p. 1920. In P. De Vos,, G. M. Garrity,, D. Jones,, N. R. Krieg,, W. Ludwig,, F. A. Rainey,, K. H. Schleifer,, and W. B. Whitman (ed.), Bergey’s Manual of Systematic Bacteriology, 2nd ed., vol. 3. The Firmicutes. Springer, New York, NY.
118. Maki, D. G.,, C. E. Weise,, and H. W. Sarafin. 1977. A semiquantitative culture method for identifying intravenouscatheter- related infection. N. Engl. J. Med. 296:13051309.
119. Martin, R. R.,, V. Buttram,, P. Besch,, J. J. Kirkland,, and G. P. Petty. 1982. Nasal and vaginal Staphylococcus aureus in young women: quantitative studies. Ann. Intern. Med. 96:951953.
120. Martineau, F.,, F. J. Picard,, D. Ke,, S. Paradis,, P. H. Roy,, M. Ouellette,, and M. G. Bergeron. 2001. Development of a PCR assay for identification of staphylococci at genus and species levels. J. Clin. Microbiol. 39:25412547.
121. Martins, A.,, and M. de Lourdes R. S. Cunha. 2007. Methicillin resistance in Staphylococcus aureus and coagulase- negative staphylococci: epidemiological and molecular aspects. Microbiol. Immunol. 51:787795.
122. Mason, W. J.,, J. S. Blevins,, K. Beenken,, N. Wibowo,, N. Ojha,, and M. S. Smeltzer. 2001. Multiplex PCR protocol for the diagnosis of staphylococcal infection. J. Clin. Microbiol. 39:33323338.
123. Mellmann, A.,, K. Becker,, C. von Eiff,, U. Keckevoet,, P. Schumann,, and D. Harmsen. 2006. Sequencing and staphylococci identification. Emerg. Infect. Dis. 12:333336.
124. Mendoza, M.,, H. Meugnier,, M. Bes,, J. Etienne,, and J. Freney. 1998. Identification of Staphylococcus species by 16S-23S rDNA intergenic spacer PCR analysis. Int. J. Syst. Bacteriol. 48:10491055.
125. Mermel, L. A.,, B. M. Farr,, R. J. Sherertz,, I. I. Raad,, N. O’Grady,, J. S. Harris,, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:12491272.
126. Miller, P. H.,, R. R. Facklam,, and J. M. Miller. 1996. Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci. J. Clin. Microbiol. 34:10271028.
127. Mitchell, R. G.,, and A. C. Baird-Parker. 1967. Novobiocin resistance and the classification of staphylococci and micrococci. J. Appl. Bacteriol. 30:251254.
128. Monday, S. R.,, and G. A. Bohach. 1999. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37:34113414.
129. Monecke, S.,, and R. Ehricht. 2005. Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin. Microbiol. Infect. 11:825833.
130. Morgan, M. 2008. Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis? J. Antimicrob. Chemother. 62:11811187.
131. Murakami, K.,, W. Minamide,, K. Wada,, E. Nakamura,, H. Teraoka,, and S. Watanabe. 1991. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:22402244.
132. Murayama, O.,, M. Matsuda,, and J. E. Moore. 2003. Studies on the genomic heterogeneity of Micrococcus luteus strains by macro-restriction analysis using pulsed-field gel electrophoresis. J. Basic Microbiol. 43:337340.
133. Murchan, S.,, M. E. Kaufmann,, A. Deplano,, R. De Ryck,, M. Struelens,, C. E. Zinn,, V. Fussing,, S. Salmenlinna,, J. Vuopio-Varkila,, N. el Solh,, C. Cuny,, W. Witte,, P. T. Tassios,, N. Legakis,, W. van Leeuwen,, A. van Belkum,, A. Vindel,, I. Laconcha,, J. Garaizar,, S. Haeggman,, B. Olsson- Liljequist,, U. Ransjo,, G. Coombes,, and B. Cookson. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:15741585.
134. Nakatomi, Y.,, and J. Sugiyama. 1998. A rapid latex agglutination assay for the detection of penicillin-binding protein 29. Microbiol. Immunol. 42:739743.
135. Novick, R. P.,, S. J. Projan,, J. Kornblum,, H. F. Ross,, G. Ji,, B. Kreiswirth,, F. Vandenesch,, and S. Moghazeh. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248: 446458.
136. Oliveira, D. C.,, C. Milheiriço,, and H. de Lencastre. 2006. Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI. Antimicrob. Agents Chemother. 50:34573459.
137. Över, U.,, Y. Tüc,, and G. Söyletir. 2000. Catalase-negative Staphylococcus aureus: a rare isolate of human infection. Clin. Microbiol. Infect. 6:681682.
138. Pan, E. S.,, B. A. Diep,, H. A. Carleton,, E. D. Charlebois,, G. F. Sensabaugh,, B. L. Haller,, and F. Perdreau-Remington. 2003. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin. Infect. Dis. 37: 13841388.
139. Paterson, D. L. 2004. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis. 38(Suppl. 4):S341S345.
140. Perry, J. D.,, A. Davies,, L. A. Butterworth,, A. L. Hopley,, A. Nicholson,, and F. K. Gould. 2004. Development and evaluation of a chromogenic agar medium for methicillin- resistant Staphylococcus aureus. J. Clin. Microbiol. 42:45194523.
141. Perry, J. D.,, C. Rennison,, L. A. Butterworth,, A. L. Hopley,, and F. K. Gould. 2003. Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus. J. Clin. Microbiol. 41:56955698.
142. Peters, G.,, R. Locci,, and G. Pulverer. 1981. Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl. Bakteriol. Mikrobiol. Hyg. B 173:293299.
143. Potoski, B. A.,, J. Adams,, L. Clarke,, K. Shutt,, P. K. Linden,, C. Baxter,, A. W. Pasculle,, B. Capitano,, A. Y. Peleg,, D. Szabo,, and D. L. Paterson. 2006. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin. Infect. Dis. 43:165171.
144. Poyart, C.,, G. Quesne,, C. Boumaila,, and P. Trieu-Cuot. 2001. Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target. J. Clin. Microbiol. 39:42964301.
145. Proctor, R. A. 2008. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46:584593.
146. Proctor, R. A.,, B. Kahl,, C. von Eiff,, P. E. Vaudaux,, D. P. Lew,, and G. Peters. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27(Suppl. 1):S68S74.
147. Proctor, R. A.,, C. von Eiff,, B. C. Kahl,, K. Becker,, P. McNamara,, M. Herrmann,, and G. Peters. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295305.
148. Raad, I.,, H. Hanna,, and D. Maki. 2007. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis. 7:645657.
149. Raad, I.,, H. A. Hanna,, B. Alakech,, I. Chatzinikolaou,, M. M. Johnson,, and J. Tarrand. 2004. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann. Intern. Med. 140:1825.
150. Rajakaruna, L.,, G. Hallas,, L. Molenaar,, D. Dare,, H. Sutton,, V. Encheva,, R. Culak,, I. Innes,, G. Ball,, A. M. Sefton,, M. Eydmann,, A. M. Kearns,, and H. N. Shah. 2009. High throughput identification of clinical isolates of Staphylococcus aureus using MALDI-TOF-MS of intact cells. Infect. Genet. Evol. 9:507513.
151. Rayner, C.,, and W. J. Munckhof. 2005. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern. Med. J. 35(Suppl. 2):S316.
152. Renneberg, J.,, K. Rieneck,, and E. Gutschik. 1995. Evaluation of Staph ID 32 system and Staph-Zym system for identification of coagulase-negative staphylococci. J. Clin. Microbiol. 33:11501153.
153. Rijnders, B. J.,, C. Verwaest,, W. E. Peetermans,, A. Wilmer,, S. Vandecasteele,, E. J. Van,, and W. E. Van. 2001. Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit. Care Med. 29:13991403.
154. Robert, J.,, R. Bismuth,, and V. Jarlier. 2006. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002. J. Antimicrob. Chemother. 57:506510.
155. Robinson, D. A.,, and M. C. Enright. 2004. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 10:9297.
156. Rogers, K. L.,, P. D. Fey,, and M. E. Rupp. 2009. Coagulasenegative staphylococcal infections. Infect. Dis. Clin. N. Am. 23:7398.
157. Roisin, S.,, C. Nonhoff,, O. Denis,, and M. J. Struelens. 2008. Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J. Clin. Microbiol. 46:25252528.
158. Rosenthal, V. D.,, D. G. Maki,, A. Mehta,, C. Álvarez- Moreno,, H. Leblebicioglu,, F. Higuera,, L. E. Cuellar,, N. Madani,, Z. Mitrev,, L. Dueñas,, J. A. Navoa-Ng,, H. G. Garcell,, L. Raka,, R. F. Hidalgo,, E. A. Medeiros,, S. S. Kanj,, S. Abubakar,, P. Nercelles,, and R. D. Pratesi. 2008. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control 36:627637.
159. Rupp, M. E.,, D. E. Soper,, and G. L. Archer. 1992. Colonization of the female genital tract with Staphylococcus saprophyticus. J. Clin. Microbiol. 30:29752979.
160. Sabat, A.,, J. Krzyszton-Russjan,, W. Strzalka,, R. Filipek,, K. Kosowska,, W. Hryniewicz,, J. Travis,, and J. Potempa. 2003. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J. Clin. Microbiol. 41:18011804.
161. Sacchidanand, S.,, R. L. Penn,, J. M. Embil,, M. E. Campos,, D. Curcio,, E. Ellis-Grosse,, E. Loh,, and G. Rose. 2005. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial. Int. J. Infect. Dis. 9:251261.
162. Saiman, L.,, M. O’Keefe,, P. L. Graham III,, F. Wu,, B. Said- Salim,, B. Kreiswirth,, A. LaSala,, P. M. Schlievert,, and P. Della-Latta. 2003. Hospital transmission of communityacquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 37:13131319.
163. Sasaki, T.,, K. Kikuchi,, Y. Tanaka,, N. Takahashi,, S. Kamata,, and K. Hiramatsu. 2007. Reclassification of phenotypically identified Staphylococcus intermedius strains. J. Clin. Microbiol. 45:27702778.
164. Schleifer, K. H.,, and W. E. Kloos. 1975. Isolation and characterization of staphylococci from human skin. I. Amended descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and descriptions of three new species: Staphylococcus cohnii, Staphylococcus haemolyticus, and Staphylococcus xylosus. Int. J. Syst. Bacteriol. 25:5061.
165. Seifert, H.,, O. Cornely,, K. Seggewiss,, M. Decker,, D. Stefanik,, H. Wisplinghoff,, and G. Fätkenheuer. 2003. Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J. Clin. Microbiol. 41:118123.
166. Seifert, H.,, M. Kaltheuner,, and F. Perdreau-Remington. 1995. Micrococcus luteus endocarditis: case report and review of the literature. Zentralbl. Bakteriol. 282:431435.
167. Seifert, H.,, D. Oltmanns,, K. Becker,, H. Wisplinghoff,, and C. von Eiff. 2005. Staphylococcus lugdunensis pacemakerrelated infection. Emerg. Infect. Dis. 11:12831286.
168. Seybold, U.,, E. V. Kourbatova,, J. G. Johnson,, S. J. Halvosa,, Y. F. Wang,, M. D. King,, S. M. Ray,, and H. M. Blumberg. 2006. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647656.
169. Shittu, A. O.,, and J. Lin. 2006. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect. Dis. 6:125.
170. Shopsin, B.,, M. Gomez,, S. O. Montgomery,, D. H. Smith,, M. Waddington,, D. E. Dodge,, D. A. Bost,, M. Riehman,, S. Naidich,, and B. N. Kreiswirth. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:35563563.
171. Skiest, D. J. 2006. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J. Clin. Microbiol. 44: 655656.
172. Skov, R.,, R. Smyth,, A. R. Larsen,, A. Bolmstrom,, A. Karlsson,, K. Mills,, N. Frimodt-Moller,, and G. Kahlmeter. 2006. Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J. Clin. Microbiol. 44:43954399.
173. Skow, A.,, K. A. Mangold,, M. Tajuddin,, A. Huntington,, B. Fritz,, R. B. ThomsonJr., and K. L. Kaul. 2005. Specieslevel identification of staphylococcal isolates by real-time PCR and melt curve analysis. J. Clin. Microbiol. 43:28762880.
174. Stackebrandt, E.,, C. Koch,, O. Gvozdiak,, and P. Schumann. 1995. Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int. J. Syst. Bacteriol. 45:682692.
175. Stackebrandt, E.,, F. A. Rainey,, and N. L. Ward-Rainey. 1997. Proposal for a new hierarchic classification system, Actinobacteria classis nov. Int. J. Syst. Bacteriol. 47:479491.
176. Stackebrandt, E.,, and P. Schumann. 2000. Description of Bogoriellaceae fam. nov., Dermacoccaceae fam. nov., Rarobacteraceae fam. nov. and Sanguibacteraceae fam. nov. and emendation of some families of the suborder Micrococcineae. Int. J. Syst. Evol. Microbiol. 50:12791285.
177. Stefani, S.,, and P. E. Varaldo. 2003. Epidemiology of methicillin- resistant staphylococci in Europe. Clin. Microbiol. Infect. 9:11791186.
178. Straub, J. A.,, C. Hertel,, and W. P. Hammes. 1999. A 23S rDNA-targeted polymerase chain reaction-based system for detection of Staphylococcus aureus in meat starter cultures and dairy products. J. Food Prot. 62:11501156.
179. Struelens, M. J.,, P. M. Hawkey,, G. L. French,, W. Witte,, and E. Tacconelli. 2009. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin. Microbiol. Infect. 15:112119.
180. Talan, D. A.,, D. Staatz,, A. Staatz,, E. J. Goldstein,, K. Singer,, and G. D. Overturf. 1989. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J. Clin. Microbiol. 27:7881.
181. Tang, Y. W.,, J. Han,, M. A. McCormac,, H. Li,, and C. W. Stratton. 2008. Staphylococcus pseudolugdunensis sp. nov., a pyrrolidonyl arylamidase/ornithine decarboxylasepositive bacterium isolated from blood cultures. Diagn. Microbiol. Infect. Dis. 60:351359.
182. Tano, K.,, R. von Essen,, P. O. Eriksson,, and A. Sjöstedt. 2008. Alloiococcus otitidis—otitis media pathogen or normal bacterial flora? APMIS 116:785790.
183. Tenover, F. C.,, R. D. Arbeit,, R. V. Goering,, P. A. Mickelsen,, B. E. Murray,, D. H. Persing,, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:22332239.
184. Tenover, F. C.,, and R. C. Moellering,Jr., 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 44:12081215.
185. Thomson-Carter, F. M.,, P. E. Carter,, and T. H. Pennington. 1989. Differentiation of staphylococcal species and strains by ribosomal RNA gene restriction patterns. J. Gen. Microbiol. 135:20932097.
186. Tokars, J. I. 2004. Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance. Clin. Infect. Dis. 39:333341.
187. Trülzsch, K.,, B. Grabein,, P. Schumann,, A. Mellmann,, U. Antonenka,, J. Heesemann,, and K. Becker. 2007. Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int. J. Syst. Evol. Microbiol. 57:15431548.
188. Valderas, M. W.,, J. W. Gatson,, N. Wreyford,, and M. E. Hart. 2002. The superoxide dismutase gene sodM is unique to Staphylococcus aureus: absence of sodM in coagulase-negative staphylococci. J. Bacteriol. 184:24652472.
189. van Belkum, A.,, N. J. Verkaik,, C. P. de Vogel,, H. A. Boelens,, J. Verveer,, J. L. Nouwen,, H. A. Verbrugh,, and H. F. Wertheim. 2009. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199:18201826.
190. Vandenesch, F.,, B. Lina,, C. Lebeau,, T. B. Greenland,, and J. Etienne. 1993. Epidemiological markers of coagulasenegative staphylococci. Intensive Care Med. 19:311315.
191. Vannuffel, P.,, J. Gigi,, H. Ezzedine,, B. Vandercam,, M. Delmee,, G. Wauters,, and J. L. Gala. 1995. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J. Clin. Microbiol. 33:28642867.
192. Vaudaux, P.,, W. L. Kelley,, and D. P. Lew. 2006. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin. Infect. Dis. 43:968970.
193. von Darányi, J. 1925. Qualitative Untersuchungen der Luftbakterien. Arch. Hyg. (Berlin) 96:182.
194. von Eiff, C.,, C. R. Arciola,, L. Montanaro,, K. Becker,, and D. Campoccia. 2006. Emerging Staphylococcus species as new pathogens in implant infections. Int. J. Artif. Organs 29:360367.
195. von Eiff, C.,, K. Becker,, K. Machka,, H. Stammer,, and G. Peters. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:1116.
196. von Eiff, C.,, D. Bettin,, R. A. Proctor,, B. Rolauffs,, N. Lindner,, W. Winkelmann,, and G. Peters. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25:12501251.
197. von Eiff, C.,, M. Herrmann,, and G. Peters. 1995. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob. Agents Chemother. 39:268270.
198. von Eiff, C.,, B. Jansen,, W. Kohnen,, and K. Becker. 2005. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65:179214.
199. von Eiff, C.,, N. Kuhn,, M. Herrmann,, S. Weber,, and G. Peters. 1996. Micrococcus luteus as a cause of recurrent bacteremia. Pediatr. Infect. Dis. J. 15:711713.
200. von Eiff, C.,, and G. Peters. 1998. In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 17:890892.
201. Walsh, T. R.,, A. Bolmstrom,, A. Qwarnstrom,, P. Ho,, M. Wootton,, R. A. Howe,, A. P. MacGowan,, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:24392444.
202. Wenzel, R. P.,, and T. M. Perl. 1995. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect. 31:1324.
203. Williams, R. E. 1963. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev. 27:5671.
204. Wilson, I. G.,, J. E. Cooper,, and A. Gilmour. 1991. Detection of enterotoxigenic Staphylococcus aureus in dried skimmed milk: use of the polymerase chain reaction for amplification and detection of staphylococcal enterotoxin genes entB and entC1 and the thermonuclease gene nuc. Appl. Environ. Microbiol. 57:17931798.
205. Wisplinghoff, H.,, T. Bischoff,, S. M. Tallent,, H. Seifert,, R. P. Wenzel,, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309317.
206. Wolk, D. M.,, L. B. Blyn,, T. A. Hall,, R. Sampath,, R. Ranken,, C. Ivy,, R. Melton,, H. Matthews,, N. White,, F. Li,, V. Harpin,, D. J. Ecker,, B. Limbago,, L. K. McDougal,, V. H. Wysocki,, M. Cai,, and K. C. Carroll. 2009. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/ electrospray ionization-mass spectrometry and correlation with phenotype. J. Clin. Microbiol. 47:31293137.
207. Wootton, M.,, R. A. Howe,, R. Hillman,, T. R. Walsh,, P. M. Bennett,, and A. P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect heteroresistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399403.
208. Wunderink, R. G.,, J. Rello,, S. K. Cammarata,, R. V. Croos- Dabrera,, and M. H. Kollef. 2003. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillinresistant Staphylococcus aureus nosocomial pneumonia. Chest 124:17891797.
209. Yamaguchi, T.,, K. Nishifuji,, M. Sasaki,, Y. Fudaba,, M. Aepfelbacher,, T. Takata,, M. Ohara,, H. Komatsuzawa,, M. Amagai,, and M. Sugai. 2002. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect. Immun. 70:58355845.
210. Zadoks, R. N.,, and J. L. Watts. 2009. Species identification of coagulase-negative staphylococci: genotyping is superior to phenotyping. Vet. Microbiol. 134:2028.
211. Zambardi, G.,, M. E. Reverdy,, S. Bland,, M. Bes,, J. Freney,, and J. Fleurette. 1994. Laboratory diagnosis of oxacillin resistance in Staphylococcus aureus by a multiplex-polymerase chain reaction assay. Diagn. Microbiol. Infect. Dis. 19:2531.
212. Zinn, C. S.,, H. Westh,, and V. T. Rosdahl. 2004. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb. Drug Resist. 10:160168.

Tables